MCID: PRC016
MIFTS: 59

Pre-Eclampsia

Categories: Reproductive diseases, Rare diseases, Cardiovascular diseases

Aliases & Classifications for Pre-Eclampsia

MalaCards integrated aliases for Pre-Eclampsia:

Name: Pre-Eclampsia 12 25 44 15 73
Preeclampsia 12 76 25 59 29 55 6
Pregnancy Associated Hypertension 12 73
Hypertension, Pregnancy-Induced, Susceptibility to 6
Proteinuric Hypertension of Pregnancy 12
Gestational Proteinuric Hypertension 25
Transient Hypertension of Pregnancy 73
Hypertension Induced by Pregnancy 12
Preeclampsia, Susceptibility to 6
Pregnancy-Induced Hypertension 25
Gestational Hypertension 12
Pre-Eclamptic Toxaemia 12
Preeclampsia/eclampsia 12
Toxaemia of Pregnancy 12
Toxemia of Pregnancy 25
Pregnancy Toxemias 55
Pregnancy Toxemia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10591
MeSH 44 D011225
Orphanet 59 ORPHA275555
ICD10 via Orphanet 34 O14.2 O14.9 O14.0 more
UMLS via Orphanet 74 C0032914

Summaries for Pre-Eclampsia

Genetics Home Reference : 25 Preeclampsia is a complication of pregnancy in which affected women develop high blood pressure (hypertension); they can also have abnormally high levels of protein in their urine (proteinuria). This condition usually occurs in the last few months of pregnancy and often requires early delivery of the infant.

MalaCards based summary : Pre-Eclampsia, also known as preeclampsia, is related to mild pre-eclampsia and eclampsia, and has symptoms including edema, hyperemesis gravidarum and morning sickness. An important gene associated with Pre-Eclampsia is H19 (H19, Imprinted Maternally Expressed Transcript
LOI of H19 can be identified in pre-eclamptic placentas and is associated with maternal blood pressures,which implies the involvement of H19 gene LOI in the pathogenesis of pre-eclampsia and its potential relationship with the severity of the disease.
Dysfunction Pattern: Mutation), and among its related pathways/superpathways are Signaling events mediated by VEGFR1 and VEGFR2 and Glypican 1 network. The drugs Methyldopa and Calcium Carbonate have been mentioned in the context of this disorder. Affiliated tissues include endothelial, placenta and testes.

Disease Ontology : 12 A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.

Wikipedia : 76 Pre-eclampsia (PE) is a disorder of pregnancy characterized by the onset of high blood pressure and... more...

Related Diseases for Pre-Eclampsia

Diseases in the Eclampsia family:

Pre-Eclampsia Severe Pre-Eclampsia

Diseases related to Pre-Eclampsia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 179)
# Related Disease Score Top Affiliating Genes
1 mild pre-eclampsia 35.9 FLT1 PGF
2 eclampsia 34.8 CORIN EPHX1 FLT1 PEE1 PGF SERPINC1
3 hellp syndrome 34.3 FLT1 PGF SERPINC1
4 placental abruption 32.2 FLT1 PGF SERPINC1
5 microvascular complications of diabetes 5 31.7 FLT1 NOS3 PGF
6 renal cell carcinoma, nonpapillary 29.8 FLT1 H19 HOTAIR MALAT1 TUG1
7 melanoma 29.4 H19 HOTAIR MALAT1 SPRY4-IT1 WFDC21P
8 severe pre-eclampsia 12.9
9 preeclampsia/eclampsia 4 12.0
10 preeclampsia/eclampsia 5 12.0
11 preeclampsia/eclampsia 1 11.6
12 gestational diabetes 11.5
13 epithelioid hemangioendothelioma 11.2 FLT1 PGF
14 arteries, anomalies of 11.2 NOS3 PGF SERPINC1
15 twin-to-twin transfusion syndrome 11.2 FLT1 PGF
16 homocysteinemia 11.1 H19 NOS3 SERPINC1
17 placenta accreta 11.1 FLT1 PGF
18 angina pectoris 11.1 NOS3 SERPINC1
19 cancer-associated retinopathy 11.0 FLT1 PGF
20 pulmonary hypertension 10.9 FLT1 MALAT1 NOS3 PGF SERPINC1
21 gastric cardia adenocarcinoma 10.9 H19 HOTAIR
22 retinal vascular occlusion 10.9 PGF SERPINC1
23 prostate disease 10.9 H19 MALAT1
24 triple-receptor negative breast cancer 10.7 HOTAIR MALAT1
25 endotheliitis 10.7
26 acute hemorrhagic leukoencephalitis 10.7 FLT1 SERPINC1
27 atherosclerosis susceptibility 10.7 H19 NOS3 TUG1
28 malignant glioma 10.7 H19 MALAT1
29 pituitary adenoma 10.6 H19 HOTAIR MALAT1
30 placenta disease 10.6
31 ovarian epithelial cancer 10.6 H19 HOTAIR MALAT1
32 kidney cancer 10.6 H19 HOTAIR MALAT1
33 pancreatic ductal adenocarcinoma 10.6 H19 HOTAIR MALAT1
34 gastrointestinal system cancer 10.6 H19 HOTAIR MALAT1
35 esophagus squamous cell carcinoma 10.5 HOTAIR TUG1
36 thyroid cancer, nonmedullary, 1 10.5 H19 HOTAIR MALAT1
37 aging 10.5
38 liver cirrhosis 10.4 HOTAIR MALAT1 SERPINC1
39 hypoxia 10.4
40 polymorphic reticulosis 10.3
41 cerebritis 10.3
42 familial hypertension 10.3
43 postpartum psychosis 10.3
44 diabetes mellitus 10.2
45 glioma 10.2 H19 HOTAIR MALAT1 SPRY4-IT1
46 hepatitis 10.2
47 thrombophilia 10.2
48 placental insufficiency 10.2
49 diabetes mellitus, noninsulin-dependent 10.2
50 hypertension, essential 10.2

Graphical network of the top 20 diseases related to Pre-Eclampsia:



Diseases related to Pre-Eclampsia

Symptoms & Phenotypes for Pre-Eclampsia

UMLS symptoms related to Pre-Eclampsia:


edema, hyperemesis gravidarum, morning sickness

Drugs & Therapeutics for Pre-Eclampsia

Drugs for Pre-Eclampsia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 431)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyldopa Approved Phase 4,Phase 2,Phase 1,Not Applicable 555-30-6 38853
2
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Not Applicable 471-34-1
3
Remifentanil Approved Phase 4,Phase 2,Phase 1 132875-61-7 60815
4
Amlodipine Approved Phase 4 88150-42-9 2162
5
Metformin Approved Phase 4,Phase 2,Phase 3,Not Applicable 657-24-9 14219 4091
6
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-78-2 2244
7
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 2180-92-9, 38396-39-3 2474
8
Dalteparin Approved Phase 4,Phase 2,Phase 3 9005-49-6
9
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
10
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3 9005-49-6 772 46507594
11
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 50-56-6 439302 53477758
12
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7440-66-6 23994
13
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
14
Oxymetazoline Approved, Investigational Phase 4,Not Applicable 1491-59-4 4636
15
Phenylephrine Approved Phase 4,Not Applicable 59-42-7 6041
16
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
17
Labetalol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable 36894-69-6 3869
18
Misoprostol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 59122-46-2 5282381
19
Benzocaine Approved, Investigational Phase 4,Phase 3,Not Applicable 1994-09-7, 94-09-7 2337
20
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
21
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7487-88-9 24083
22
Furosemide Approved, Vet_approved Phase 4,Phase 2 54-31-9 3440
23
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
24
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Not Applicable 15687-27-1 3672
25
Captopril Approved Phase 4 62571-86-2 44093
26
Clonidine Approved Phase 4,Phase 1,Phase 2,Not Applicable 4205-90-7 2803
27
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
28
Insulin Aspart Approved Phase 4,Phase 3,Not Applicable 116094-23-6 16132418
29
Insulin Lispro Approved Phase 4,Not Applicable 133107-64-9
30
Glyburide Approved Phase 4,Not Applicable 10238-21-8 3488
31
Nifedipine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 21829-25-4 4485
32
Azithromycin Approved Phase 4,Phase 3,Not Applicable 83905-01-5 55185 447043
33
Warfarin Approved Phase 4 81-81-2 6691 54678486
34
Desogestrel Approved Phase 4 54024-22-5 40973
35
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
36
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 77-92-9 311
37
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-30-3 6037
38
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Not Applicable 58-05-9 143 6006
39
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2,Not Applicable 50-14-6 5280793
40
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1406-16-2
41
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 67-97-0 6221 5280795
42 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Not Applicable
43
Serine Approved, Nutraceutical Phase 4,Phase 3 56-45-1 5951
44 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Bone Density Conservation Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
46 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Adrenergic Agonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Adrenergic alpha-2 Receptor Agonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
50 Adrenergic alpha-Agonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 724)
# Name Status NCT ID Phase Drugs
1 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4 methildopa;placebo
2 Low Dose Calcium to Prevent Preeclampsia Unknown status NCT02338687 Phase 4
3 Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Unknown status NCT00117546 Phase 4 alpha methyldopa
4 Remifentanil for General Anesthesia in Preeclamptics Unknown status NCT00567957 Phase 4 Remifentanil;Saline
5 Viagra for the Treatment of IUGR Unknown status NCT00347867 Phase 4 Viagra administration in IUGR/PET pregnancies
6 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Unknown status NCT02353806 Phase 4 Amlodipine besylate
7 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
8 Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia Unknown status NCT01718340 Phase 4 Metformin
9 Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Completed NCT01729468 Phase 4 Aspirin;Placebo
10 Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia Completed NCT02699827 Phase 4 Levobupivacaine hydrochloride;Magnesium sulphate;Saline 0.9%
11 Treatment Approaches to Preeclampsia Completed NCT01030627 Phase 4
12 Diuretics for Postpartum High Blood Pressure in Preeclampsia Completed NCT02163655 Phase 4 FUROSEMIDE;Placebo
13 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4 Acetylsalicylic Acid;Acetylsalicylic Acid
14 Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia Completed NCT01408979 Phase 4 Magnesium sulfate 12 hours;Magnesium sulfate 24 hours
15 The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy Completed NCT02891174 Phase 4 Ibuprofen;Acetaminophen
16 A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen Completed NCT02091401 Phase 4 Magnesium Sulfate
17 Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure Completed NCT01761916 Phase 4 CLONIDINE;CAPTOPRIL
18 Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients Completed NCT01972659 Phase 4 placebo;Magnesium Sulphate;sugammadex
19 Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies Completed NCT01608347 Phase 4 LMWH+Folic acid;Folic Acid
20 Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Completed NCT00790062 Phase 4 Oxytocin
21 Timing of Initiation of LMWH Administration in Pregnant Women With APS Completed NCT02326051 Phase 4 Enoxaparin;Enoxaparin
22 Metformin Versus Insulin in Gestational Diabetes Completed NCT01240785 Phase 4 metformin;insulin
23 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Completed NCT02466204 Phase 4 corifollitropin alfa;Follitropin Beta
24 Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo Completed NCT00744965 Phase 4 Glyburide;Placebo
25 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Completed NCT02377349 Phase 4 Saline placebo
26 Impact of Antichlamydial Treatment on the Rate of Preeclampsia Recruiting NCT03233880 Phase 4 Azithromycin 1gm
27 Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia Recruiting NCT03164304 Phase 4 Magnesium Sulfate
28 Phenylephrine Versus Ephedrine in Pre-eclampsia Recruiting NCT02025426 Phase 4 Phenylephrine;Ephedrine
29 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Recruiting NCT02920593 Phase 4 Vitamin D3
30 Early Vascular Adjustments During Hypertensive Pregnancy Recruiting NCT02531490 Phase 4 Labetalol;Nifedipine;Methyldopa
31 Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension Recruiting NCT03449277 Phase 4 Oral Tablet
32 Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy Recruiting NCT01912677 Phase 4 Nifedipine;Labetalol;Methyldopa
33 Response to Anti-hypertensives in Pregnant and Postpartum Patients Recruiting NCT03506724 Phase 4 Nifedipine;Labetalol
34 ENOXAPARINE in the Prevention of Placental Insufficiency in Pregnant Women Recruiting NCT03528967 Phase 4 Enoxaparin 40 mg / 0.4 mL Prefilled Syringe;Aspirin 100 mg Oral Tablet, Enteric Coated
35 Chronotherapy With Low-dose Aspirin for Primary Prevention Recruiting NCT00725127 Phase 4 aspirin;aspirin
36 Chronic Hypertension and Pregnancy (CHAP) Project Recruiting NCT02299414 Phase 4 Anti-hypertensive therapy
37 Use of Warfarin After the First Trimester in Pregnant Women With APS Recruiting NCT02303171 Phase 4 Enoxaparin;Warfarin
38 Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology Recruiting NCT03177122 Phase 4 Myo-inositol
39 A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor Recruiting NCT02777190 Phase 4 Misoprostol
40 Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Active, not recruiting NCT02911701 Phase 4 Acetaminophen;Ibuprofen
41 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4 etonogestrel-releasing implant contraceptive
42 Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial Not yet recruiting NCT03318211 Phase 4 Magnesium Sulfate
43 Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus Not yet recruiting NCT03570632 Phase 4 Metformin
44 Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients Not yet recruiting NCT03237000 Phase 4 MgSO4
45 Different Schemes of Magnesium Sulfate for Preeclampsia Terminated NCT02396030 Phase 4 Magnesium sulfate 50% - 1g/h;Magnesium sulfate 50% - 2g/h
46 Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension Terminated NCT00449618 Phase 4 Aspirin 100 mg;Placebo
47 Atenativ Effect on Uterine Blood Flow and Preeclampsia Withdrawn NCT02278575 Phase 4 Atenativ
48 Failure Rate of GLyburide And Metformin Among Gestational Diabetics Withdrawn NCT03078725 Phase 4 Glyburide;Metformin
49 RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section Withdrawn NCT02009098 Phase 4 Cefuroxime
50 Low Dose Aspirin for the Prevention of Preeclampsia Unknown status NCT01890005 Phase 3 Aspirin;Placebo

Search NIH Clinical Center for Pre-Eclampsia

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pre-eclampsia

Genetic Tests for Pre-Eclampsia

Genetic tests related to Pre-Eclampsia:

# Genetic test Affiliating Genes
1 Preeclampsia 29 EPHX1 NOS3

Anatomical Context for Pre-Eclampsia

MalaCards organs/tissues related to Pre-Eclampsia:

41
Endothelial, Placenta, Testes, Lung, Liver, Thyroid, Kidney

Publications for Pre-Eclampsia

Articles related to Pre-Eclampsia:

(show top 50) (show all 1772)
# Title Authors Year
1
Is it time to move towards non-invasive prenatal screening for Down syndrome and screening for pre-eclampsia? ( 29446241 )
2018
2
Hemoglobin levels during the first trimester of pregnancy are associated with the risk of gestational diabetes mellitus, pre-eclampsia and preterm birth in Chinese women: a retrospective study. ( 29940874 )
2018
3
The feasibility of task-sharing the identification, emergency treatment, and referral for women with pre-eclampsia by community health workers in India. ( 29945662 )
2018
4
Maternal cardiac output response to colloid preload and vasopressor therapy during spinal anaesthesia for caesarean section in patients with severe pre-eclampsia: a randomised, controlled trial. ( 29086911 )
2018
5
Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia. ( 29438905 )
2018
6
Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. ( 29367581 )
2018
7
Quality assessment of uterine artery Doppler measurement in first trimester combined screening for pre-eclampsia. ( 29917286 )
2018
8
Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. ( 29978553 )
2018
9
Screening for pre-eclampsia at 35-37 weeks' gestation. ( 29896778 )
2018
10
Elabela-APJ axis contributes to embryonic development and prevents pre-eclampsia in pregnancy. ( 29342224 )
2018
11
Decidual regulation of trophoblast is altered in pregnancies at risk of pre-eclampsia. ( 29437882 )
2018
12
Measurement of area difference ratio of Photoplethysmographic pulse wave in patients with pre-eclampsia. ( 29970018 )
2018
13
Streptococcus pyogenes subdural empyema and pre-eclampsia. ( 29582773 )
2018
14
Associations between the timing and dosing of aspirin prophylaxis and term and preterm pre-eclampsia. ( 29880699 )
2018
15
Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy. ( 29789925 )
2018
16
A case of partial hydatidiform molar pregnancy with a placental diploid-triploid mosaicism associated with a euploid viable foetus complicated with severe pre-eclampsia. ( 29421928 )
2018
17
Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia. ( 29145147 )
2018
18
Three-dimensional indices of renal perfusion in normal pregnancy and pre-eclampsia. ( 29916133 )
2018
19
Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies. ( 29405972 )
2018
20
Study on the correlation between adipocyte fatty-acid binding protein, glucolipid metabolism, and pre-eclampsia. ( 29316087 )
2018
21
Utility of serology in the diagnosis of pre-eclampsia and haemolytic uraemic syndrome in pregnancy-related acute kidney injury. ( 29890047 )
2018
22
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13a88weeks' gestation. ( 29896812 )
2018
23
Re: Placental histopathology associated with pre-eclampsia: a systematic review and meta-analysis. ( 29417682 )
2018
24
Prediction and prevention of pre-eclampsia in Asian subpopulation. ( 29442407 )
2018
25
HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia. ( 29941324 )
2018
26
Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe? ( 29907146 )
2018
27
Baseline check of blood pressure readings of an automated device in severe pre-eclampsia and healthy normotensive pregnancy. ( 29674198 )
2018
28
Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia. ( 29318732 )
2018
29
Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia. ( 29093565 )
2018
30
Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models. ( 29970026 )
2018
31
Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis. ( 29436313 )
2018
32
Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia: Efficacy and foetal outcome: a randomised double-blinded trial. ( 29432379 )
2018
33
The potential therapeutic effects of ergothioneine in pre-eclampsia. ( 29284116 )
2018
34
Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia. ( 29895936 )
2018
35
Molar pregnancy with normal viable fetus presenting with severe pre-eclampsia: a case report. ( 29779493 )
2018
36
Pre-eclampsia affects procalcitonin production in placental tissue. ( 29427369 )
2018
37
Pre-Eclampsia: A Twilight Zone Between Health and Cardiovascular Disease? ( 29957220 )
2018
38
Twin gestation in a Swyer syndrome patient with superimposed pre-eclampsia. ( 29421927 )
2018
39
Acute Cardiac Effects of SevereA Pre-Eclampsia. ( 29957219 )
2018
40
Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control study. ( 29914672 )
2018
41
Effect of iron supplementation during early pregnancy on the development of gestational hypertension and pre-eclampsia. ( 29951711 )
2018
42
Severe pre-eclampsia among pregnant women with sickle cell disease and HIV. ( 29523281 )
2018
43
Transient diabetes insipidus in a post-partum woman with pre-eclampsia associated with residual placental vasopressinase activity. ( 29850023 )
2018
44
Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. ( 29304392 )
2018
45
Management of pregnancies after combined screening for pre-eclampsia at 19-24a88weeks' gestation. ( 29943498 )
2018
46
Assessment of Relationship of Serum Neurokinin-B Level in the Pathophysiology of Pre-eclampsia: A Case-Control Study. ( 29923045 )
2018
47
Determinants of pre-eclampsia/Eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: a case control study. ( 28915802 )
2017
48
Validation of a first-trimester screening model for pre-eclampsia in an unselected population. ( 27257033 )
2017
49
Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction. ( 28503744 )
2017
50
Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia. ( 28475234 )
2017